Ursodeoxycholic Acid Suppliers, Ursodeoxycholic Acid Manufacturers.
Zhongshan Belling Bio Technology Co., Ltd.
Ursodeoxycholic Acid
Category :
Pharmaceuticals and BiochemicalsSynonyms :
3,7-Dihydroxycholan-24-oic acid;3alpha,7beta-Dihydroxy-6beta-cholan-24-oic acid;Ursodiol;2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethanol;(3alpha,5beta,7alpha)-3,7-dihydroxycholan-24-oic acid;(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid;(4R)-4-[(3R,5S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid;(4R)-4-[(3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid;(3alpha,5beta,7beta,8xi,9xi,14xi)-3,7-dihydroxycholan-24-oic acid;(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oate;(3alpha,5alpha,7beta)-3,7-dihydroxycholan-24-oate;CAS NO :
128-13-2EC NO :
204-879-3Molecular Formula :
C24H39O4Molecular Weight :
391.5646Main Specifications :
EP6/7, BP, USP, JPInChI :
InChI=1/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/p-1/t14-,15-,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1Packing :
25kg/barrelProduct description :
CAS No. : [128-13-2] Spec : In-house Supply : Commercial Name Ursodeoxycholic acid Synonyms 3,7-Dihydroxycholan-24-oic acid; 3alpha,7beta-Dihydroxy-6beta-cholan-24-oic acid; Ursodiol Molecular Formula C24H40O4 Molecular Weight 392.58 CAS Registry Number 128-13-2Uses :
The drug reduces cholesterol absorption and is used to dissolve (cholesterol) gallstones in patients who want an alternative to surgery.It is the only FDA approved drug to treat primary biliary cirrhosis.Molecular Structure :

World Wide ChemNet: - International - China - Korea
About Us - Top Products- Partner with Us - Contact Us - Help - Sitemap
About Us - Top Products- Partner with Us - Contact Us - Help - Sitemap
ChemNet is a registered trademark of Zhejiang NetSun Co., Ltd.
